en
Crystal Pharmatech will be at AAPS Booth #3345 to share practical formulation work and approaches that keep early development on track. If you're building data packages for IND or optimizing a clinical formulation, we'd value the chance to talk through methods, trade-offs, and what's worked in recent programs.
Tuesday 11/11 - Forum 8, Monitor 52
1:30–2:30 PM — Developing a Minitablet Formulation for an NCE to Enable Dose and Administration Flexibility in Pediatric Clinical Trials
2:30–3:30 PM — Overcoming Formulation Challenges of an Unstable Amorphous Prodrug by API-Sparing and Enteric Coating Approaches
3:30–4:30 PM — Development of a Gastro-Retentive Bimodal Release Bilayer Tablet to Enable Once-Daily Dosing, Fast Onset, and Blunted Cmax for an NCE with Short Half-Life
We're happy to compare workflows (API-sparing screens, risk triage, release design, scale-up considerations) and share lessons learned that help avoid rework and conserve material.
Schedule a meeting with us: contact@crystalpharmatech.com
When: November 9–12, 2025
Where: Henry B. González Convention Center, San Antonio, TX
Find Us: Booth #3345
Developing a Minitablet Formulation for an NCE to Enable Dose and Administration Flexibility in Pedi
